Skip to main content
Anthony Chiurco, MD, Neurosurgery, Lawrenceville, NJ, Capital Health Regional Medical Center

AnthonyAlfredChiurcoMD

Neurosurgery Lawrenceville, NJ

Assistant Clinical Professor of Neurological Surgery

Dr. Chiurco is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Chiurco's full profile

Already have an account?

  • Office

    3131 Princeton Pike
    Building 4, Suite 201
    Lawrenceville, NJ 08648
    Phone+1 609-895-8898
    Fax+1 609-895-8330
  • Is this information wrong?

Education & Training

  • University of Iowa Hospitals and Clinics
    University of Iowa Hospitals and ClinicsResidency, Neurological Surgery, 1971 - 1975
  • University of Iowa Hospitals and Clinics
    University of Iowa Hospitals and ClinicsResidency, Surgery, 1970 - 1971
  • Presbyterian Medical Center of the University of Pennsylvania Health System
    Presbyterian Medical Center of the University of Pennsylvania Health SystemInternship, Transitional Year, 1967 - 1968
  • Sidney Kimmel Medical College at Thomas Jefferson University
    Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1967

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 1976 - 2025
  • American Board of Neurological Surgery Neurological Surgery

Awards, Honors, & Recognition

  • Fellow (FACS) American College of Surgeons
  • Fellow (FAANS) American Association of Neurological Surgeons

Press Mentions

  • Imvax Announces Publication of Phase 1b Clinical Trial of IGV-001 for Patients with Newly Diagnosed Glioblastoma in Clinical Cancer Research
    Imvax Announces Publication of Phase 1b Clinical Trial of IGV-001 for Patients with Newly Diagnosed Glioblastoma in Clinical Cancer ResearchJanuary 26th, 2021
  • Imvax Announces Positive Results from Clinical Trial of Novel IGV-001 Autologous Cell Vaccine in Treating Patients with Newly Diagnosed Glioblastoma
    Imvax Announces Positive Results from Clinical Trial of Novel IGV-001 Autologous Cell Vaccine in Treating Patients with Newly Diagnosed GlioblastomaApril 20th, 2019

Professional Memberships

Hospital Affiliations